tirzepatide 2024 and Injectable Semaglutide Correlated with Greatest Weight Loss Among GLP-1 Medications Tirzepatide Once Weekly in Children
Description
Ozempic, Wegovy, Mounjaro, and Zepbound and their delivery device are registered trademarks
If a patient is successful with any given medication but reaches a weight loss plateau (typically defined as no weight loss over 1-3 months), the medication should not be discontinued abruptly as it may lead to weight regain
At 15 mg, the same premature injection could produce severe GI distress
Inject subcutaneously, not intramuscularly
